PRTA - PROTHENA CORP PUBLIC LTD CO
10.79
-0.110 -1.019%
Share volume: 318,913
Last Updated: 04-20-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.17%
PREVIOUS CLOSE
CHG
CHG%
$10.90
-0.11
-0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-08-2024 | 08-08-2024 | 11-12-2024 | 02-27-2025 | 05-08-2025 | 08-04-2025 | 11-06-2025 | 02-27-2026 | |
| Total revenue | 50.000 K | 132.014 M | 970.000 K | 2.123 M | 2.828 M | 4.420 M | 2.415 M | 21.000 K | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 50.000 K | 132.014 M | 970.000 K | 2.123 M | 2.828 M | 4.420 M | 2.415 M | 21.000 K | |
| 263,928.00% | -99.27% | 118.87% | 33.21% | 56.29% | -45.36% | -99.13% | |||
| Operating expenses | 81.578 M | 73.637 M | 67.483 M | 67.020 M | 68.409 M | 56.427 M | 42.176 M | 27.232 M | |
| Selling general and admin | 17.464 M | 16.127 M | 16.760 M | 16.848 M | 17.598 M | 15.910 M | 13.238 M | 12.646 M | |
| Research and development | 64.114 M | 57.510 M | 50.723 M | 50.172 M | 50.811 M | 40.517 M | 28.938 M | 14.586 M | |
| Total expenses | 81.578 M | 73.637 M | 67.483 M | 67.020 M | 68.409 M | 89.036 M | 42.655 M | 24.224 M | |
| -9.73% | -8.36% | -0.69% | 2.07% | 30.15% | -52.09% | -43.21% | |||
| Operating income | -81.528 M | 58.377 M | -66.513 M | -64.897 M | -65.581 M | -84.616 M | -40.240 M | -24.203 M | |
| Ebit | -81.528 M | 58.326 M | -66.579 M | -64.888 M | -65.721 M | -84.759 M | -40.263 M | -24.225 M | |
| Pretax income | -74.440 M | 64.847 M | -59.836 M | -59.501 M | -61.373 M | -80.965 M | -36.912 M | -21.579 M | |
| -187.11% | -192.27% | -0.56% | 3.15% | 31.92% | -54.41% | -41.54% | |||
| Income tax | -2.201 M | -2.039 M | -835.000 K | -1.545 M | -1.178 M | 44.802 M | -371.000 K | 10.000 K | |
| Net income basic | -72.239 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| 100.00% | |||||||||
| Net income | -72.239 M | 66.886 M | -59.001 M | -57.956 M | -60.195 M | -125.767 M | -36.541 M | -21.589 M | |
| 192.59% | -188.21% | 1.77% | -3.86% | -108.93% | 70.95% | 40.92% |